Terumo Corporation completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders.

marketscreener
2025.10.30 18:25
portai
I'm PortAI, I can summarize articles.

Terumo Corporation has completed the acquisition of a 99.5% stake in OrganOx Limited for $1.5 billion, making it a wholly owned subsidiary. The deal, finalized on October 30, 2025, was funded through cash and borrowings. OrganOx reported total revenue of $69.14 million and EBIT of $9.01 million for the year ending December 31, 2024. The transaction was advised by Perella Weinberg Partners and Piper Sandler, with legal counsel from Latham & Watkins.

Source: marketscreener The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.